COVID-19
Not recruitingStudy on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
Cyprus- Participants:18–64 years · 65+ years
- Substances:Abatacept
Rare diseases
Investigational molecules
Locations
Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
CyprusStudy on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus
DenmarkStudy on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists
BulgariaStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
BelgiumStudy on Linaclotide for Treating Functional Constipation in Children Aged 6 Months to Less Than 2 Years
BulgariaStudy of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer
AustriaStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
AustriaStudy on the Safety and Pain Relief of Nasal Spray with Ketamine Hydrochloride and Sufentanil Citrate for Children with Moderate to Severe Pain
SpainStudy on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression
CzechiaStudy of MP0533 for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Using Sodium Dihydrogen Phosphate Dihydrate, Polysorbate 20, and Sodium Chloride
FranceStudy of Brentuximab Vedotin, Doxorubicin Hydrochloride, and Dacarbazine for Patients with Untreated Classical Hodgkin Lymphoma
CzechiaStudy on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.